Navigation Links
Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit

Philadelphia, Pennsylvania (PRWEB) February 21, 2013

Within an ever-changing business environment there is an unquestionable need for organizations to become analytically competitive, innovative and agile. Building on IE. – Innovation Enterprise’s history of successful summits in this sector, the Financial Planning & Analysis for Pharma & Biotech event will bring together over 200+ senior finance leaders in a unique, collaborative environment.

With over 25 distinguished keynote speakers including: Director, Finance, Pfizer, Senior Director, Finance, Johnson & Johnson and Senior Director, Finance, Siemens Healthcare, this summit will provide attendees with an exclusive insight into processes at the most forward thinking organizations currently in the industry.

Commenting on the 2012 event a previous attendee noted: “This summit is unique in that it covers both financially and industry relevant topics. It’s an excellent opportunity to share and exchange information and knowledge with high level and international professionals.” From the 120 delegates at last year’s event, over 80% recommended the event to a colleague with a further 87% rating the summit as “good to excellent”.

Emma Flanagan, International Events Director at IE. – Innovation Enterprise: “From our research into the market it became clear that finance leaders are looking for a forum to exchange ideas with peers of a similar stature and experience. This summit was specifically designed for senior level attendees. It’s exclusive, CPE accredited and we’re really proud of the agenda that we’ve organized.”

Running concurrently to the Pharma & Biotech summit is the Financial Planning & Analysis in Healthcare Summit where speakers from companies such as the American Academy of Physician Assistants and DaVita will be congregating to discuss their challenges and best practices in a no holds barred environment.

For a complete list of speakers, agenda and registration details for the Financial Planning & Analysis for Pharma & Biotech Summit please visit:

About IE.: The Innovation Enterprise Ltd, a CFO Publishing company is an independent business-to-business multi-channel media brand focused on the information needs of Senior Finance, Operations, Planning, Strategy, Decision Support & Advanced Analytics executives. Products include IE.Summits, IE.Finance, IE.Analytics, IE.Operations, IE.Strategy, IE.Membership and IE.Insights. Whether it's delivered online, or in person, everything IE produces reflects the company's unshakeable belief in the power of information to spur innovation.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. Amarantus Bioscience Launches Online Corporate Communication Channels
4. China Cord Blood Corporation to Further Consolidate its Corporate Structure
5. 2012 Battalia Winston Survey Finds Corporate Holiday Parties are Making a Comeback
6. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
7. CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
8. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
9. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
10. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
11. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
Post Your Comments:
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving air ... living in larger cities are affected by air pollution related diseases. , That is ... globally - decided to take action. , “I knew I had to take action ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... Dr. Bob ... at his local San Diego Rotary Club. The event entitled “Stem ... CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... NEW YORK , April 5, 2017 ... security, is announcing that the server component of the ... is known for providing the end-to-end security architecture that ... customers. HYPR has already secured over 15 ... system makers including manufacturers of connected home product suites ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
Breaking Biology News(10 mins):